优化Behçet膜炎的葡萄糖皮质类药物治疗:疗效,不良反应和组合治疗方法的进展
Biao Li1, Haoran Li1, Qun Huang1
1Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
International ophthalmology
|July 7, 2023
概括
葡萄糖皮质类药物 (GCS) 对于贝塞特膜炎 (BU) 是至关重要的,但有副作用. 将GCS与其他疗法结合起来可以改善结果,并降低视力保护的风险.
科学领域:
- 眼科医生 眼科 眼科
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
背景情况:
- 贝塞特膜炎 (Behcet's uveitis,BU) 是贝塞特病的一个严重的眼部表现,具有明显的视力丧失风险.
- 葡萄糖皮质类药物 (GCS) 是BU的主要治疗方法,但长期使用与相当大的不良影响有关.
研究的目的:
- 审查GCS在BU管理中的有效性和不良影响.
- 探索涉及GCS用于BU的组合疗法的进展.
- 评估不同的GCS给药途径,以获得最佳的患者结果.
主要方法:
- 对Behçet膜炎的GCS治疗当前文献的系统综述.
- 管理途径的分析:全身注射,周眼注射,视内注射和持续释放装置.
- 评估与免疫抑制剂和生物药物的联合策略.
主要成果:
- 不同的GCS管理途径提供不同的风险-收益概况.
- 持续释放的配方 (fluocinolone乙胺,德克萨米他) 是关键的.
- 与免疫抑制剂和生物药物联合治疗对于减轻GCS副作用和提高疗效至关重要.
结论:
- 在BU治疗中,GCS仍然是基本的,但战略管理至关重要.
- 将GCS与其他药物结合使用对于控制不良反应和实现长期缓解至关重要.
- 优化治疗策略可以改善BU患者的视觉结果.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
156
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
156
Open Angle Glaucoma: Treatment
481
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
481
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
309
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
309
Inflammatory Bowel Disease IV: Pharmacological Management
155
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
155
COPD: Management Using Bronchodilators and Corticosteroids
250
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
250
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
200
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
200


